U.S.'s Trovagene and UAE's Alliance Global (AGBL) sign a medical distribution agreement
22 February, 2017 Trovagene, Inc. (NASDAQ: TROV), (San Diego, CA), a developer of circulating tumor DNA (ctDNA) technologies, signed a distribution agreement with AGBL (Dubai, UAE) to bring Trovagene Liquid Biopsy tests to AGBL’s markets. “Trovagene has innovative liquid biopsy solutions for cancer patients,” said Dr. Simona Maciotta, Product Manager at AGBL. “Their clinically, actionable, highly sensitive mutation assays will allow clinicians to make critical decisions about […]